← Back to guidelines
Otolaryngology (ENT)325 papers

Sensorineural deafness and male infertility

Last edited: 4/15/2026

Overview

Sensorineural deafness involves damage to the inner ear or auditory nerve, leading to hearing impairment. Certain genetic mutations, such as those in the GJB2 gene encoding connexin 26, can cause sensorineural deafness alongside mucocutaneous manifestations 2.

Diagnosis

  • Genetic Testing: Identify mutations in GJB2 gene, particularly F142L mutation 2.
  • Audiometry: Assess hearing thresholds to confirm sensorineural hearing loss.
  • Imaging: MRI or CT scans may be considered to rule out structural abnormalities [Not explicitly covered in abstracts].
  • Clinical Examination: Look for associated mucocutaneous symptoms like hyperkeratotic plaques and parakeratosis 2.
  • Management

  • Hearing Aids: Primary intervention for managing sensorineural hearing loss [Not explicitly covered in abstracts].
  • Cochlear Implants: For severe to profound hearing loss unresponsive to hearing aids [Not explicitly covered in abstracts].
  • Supportive Care: Management of mucocutaneous symptoms with dermatological treatments as needed 2.
  • Special Populations

  • Pediatrics: Early genetic testing and intervention crucial for developmental outcomes [Not explicitly covered in abstracts].
  • Comorbidities: No specific guidance provided in abstracts regarding comorbidities [Not explicitly covered in abstracts].
  • Key Recommendations

  • Conduct genetic testing for GJB2 mutations in patients presenting with sensorineural deafness and mucocutaneous symptoms (Evidence: Moderate 2).
  • Implement early audiometric evaluation in pediatric patients suspected of sensorineural deafness (Evidence: Expert opinion [Not explicitly covered in abstracts]).
  • Consider multidisciplinary care involving dermatology for managing associated mucocutaneous manifestations (Evidence: Expert opinion 2).
  • References

    1 Litvack JR, Lindsay RW. Moving Toward Professional Equity in Otolaryngology. Otolaryngologic clinics of North America 2022. link 2 Ibáñez MM, Alcalde MM, Jiménez MR, Muñoz MD, Díez-Delgado FJ. An unusual mucocutaneous syndrome with sensorineural deafness due to connexin 26 mutations. Pediatric dermatology 2013. link

    Original source

    1. [1]
      Moving Toward Professional Equity in Otolaryngology.Litvack JR, Lindsay RW Otolaryngologic clinics of North America (2022)
    2. [2]
      An unusual mucocutaneous syndrome with sensorineural deafness due to connexin 26 mutations.Ibáñez MM, Alcalde MM, Jiménez MR, Muñoz MD, Díez-Delgado FJ Pediatric dermatology (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG